DE20004692U1
(en)
|
2000-03-14 |
2001-07-26 |
Sofamor Danek Gmbh |
Vertebral implant for screwing into an intervertebral space
|
US6150328A
(en)
*
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
US5284756A
(en)
*
|
1988-10-11 |
1994-02-08 |
Lynn Grinna |
Heterodimeric osteogenic factor
|
US5656593A
(en)
*
|
1991-03-11 |
1997-08-12 |
Creative Biomolecules, Inc. |
Morphogen induced periodontal tissue regeneration
|
CA2363965C
(en)
|
1991-03-11 |
2010-05-18 |
Curis, Inc. |
Protein-induced morphogenesis
|
US6495513B1
(en)
|
1991-03-11 |
2002-12-17 |
Curis, Inc. |
Morphogen-enhanced survival and repair of neural cells
|
US6287816B1
(en)
*
|
1991-06-25 |
2001-09-11 |
Genetics Institute, Inc. |
BMP-9 compositions
|
JP3504263B2
(en)
|
1991-11-04 |
2004-03-08 |
ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー |
Recombinant bone morphogenetic protein heterodimers, compositions and uses
|
AU677849B2
(en)
*
|
1993-05-12 |
1997-05-08 |
Genetics Institute, Llc |
BMP-10 compositions
|
DE69433530T2
(en)
*
|
1993-05-12 |
2005-01-05 |
Genetics Institute, LLC, Cambridge |
BMP-11 COMPOSITIONS
|
US6333168B1
(en)
*
|
1993-05-20 |
2001-12-25 |
The Trustees Of Columbia University In The City Of New York |
Cloning, expression and uses of dorsalin-1
|
ATE326234T1
(en)
*
|
1993-08-26 |
2006-06-15 |
Genetics Inst Llc |
HUMAN BONE MORPHOGENETIC PROTEINS FOR USE IN NEURONAL REGENERATION
|
ES2255059T3
(en)
*
|
1993-12-07 |
2006-06-16 |
Genetics Institute, Llc |
BMP-12, BMP-13 AND YOUR INDUCTION COMPOSITIONS OF TENDON.
|
US6027919A
(en)
*
|
1993-12-07 |
2000-02-22 |
Genetics Institute, Inc. |
BMP-12 and BMP-13 proteins and DNA encoding them
|
US5399677A
(en)
*
|
1993-12-07 |
1995-03-21 |
Genetics Institute, Inc. |
Mutants of bone morphogenetic proteins
|
US5942496A
(en)
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
US6551618B2
(en)
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
US5906827A
(en)
*
|
1994-06-03 |
1999-05-25 |
Creative Biomolecules, Inc. |
Matrix for the manufacture of autogenous replacement body parts
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US5645084A
(en)
*
|
1995-06-07 |
1997-07-08 |
Danek Medical, Inc. |
Method for spinal fusion without decortication
|
US5635372A
(en)
*
|
1995-05-18 |
1997-06-03 |
Genetics Institute, Inc. |
BMP-15 compositions
|
AU699918B2
(en)
|
1995-06-05 |
1998-12-17 |
Genetics Institute, Llc |
Methods and compositions for healing and repair of connective tissue attachment
|
US5902785A
(en)
*
|
1995-06-06 |
1999-05-11 |
Genetics Institute, Inc. |
Cartilage induction by bone morphogenetic proteins
|
US6407060B1
(en)
|
1996-03-22 |
2002-06-18 |
Curis, Inc. |
Method for enhancing functional recovery following central nervous system ischemia or trauma
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
US6492508B1
(en)
|
1996-06-03 |
2002-12-10 |
United States Surgical Corp. A Division Of Tyco Healthcare Group |
Nucleic acids encoding extracellular matrix proteins
|
US5965403A
(en)
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
US6037519A
(en)
*
|
1997-10-20 |
2000-03-14 |
Sdgi Holdings, Inc. |
Ceramic fusion implants and compositions
|
CA2280931C
(en)
|
1997-02-07 |
2009-05-05 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
US6034062A
(en)
*
|
1997-03-13 |
2000-03-07 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-9 compositions and their uses
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
CA2291514C
(en)
|
1997-05-30 |
2011-07-12 |
Creative Biomolecules, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
US5972368A
(en)
*
|
1997-06-11 |
1999-10-26 |
Sdgi Holdings, Inc. |
Bone graft composites and spacers
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
EP1007673B1
(en)
|
1997-07-30 |
2008-12-17 |
Emory University |
Novel bone mineralization proteins, dna, vectors, expression systems
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
US6511509B1
(en)
|
1997-10-20 |
2003-01-28 |
Lifenet |
Textured bone allograft, method of making and using same
|
US6027917A
(en)
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
EP2050762A3
(en)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Human cornichon-like protein and nucleic acids encoding it
|
EP1064382B1
(en)
|
1998-03-17 |
2008-08-20 |
Genentech, Inc. |
Polypeptides homologous to vegf and bmp1
|
US6211157B1
(en)
|
1998-05-01 |
2001-04-03 |
Sulzer Biologics, Inc. |
Protein mixtures to induce therapeutic angiogenesis
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
EP1102568A1
(en)
|
1998-08-06 |
2001-05-30 |
SDGI Holdings, Inc. |
Composited intervertebral bone spacers
|
US6849255B2
(en)
|
1998-08-18 |
2005-02-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods and compositions for enhancing cartilage repair
|
US6992066B2
(en)
*
|
1998-10-16 |
2006-01-31 |
Zimmer Orthobiologics, Inc. |
Povidone-containing carriers for polypeptide growth factors
|
US7087577B2
(en)
*
|
1998-10-16 |
2006-08-08 |
Zimmer Orthobiologies, Inc. |
Method of promoting natural bypass
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
EP1223990B1
(en)
|
1999-10-15 |
2004-07-28 |
Genetics Institute, LLC |
Formulations of hyaluronic acid for delivery of osteogenic proteins
|
DK1244388T3
(en)
|
1999-12-06 |
2007-05-14 |
Warsaw Orthopedic Inc |
Device for treating intervertebral discs
|
US20060078847A1
(en)
*
|
2000-09-29 |
2006-04-13 |
Kwan Norman H |
Dental implant system and additional methods of attachment
|
ES2326467T3
(en)
|
2000-12-08 |
2009-10-13 |
Osteotech, Inc. |
IMPLANT FOR ORTHOPEDIC APPLICATIONS.
|
US6752831B2
(en)
|
2000-12-08 |
2004-06-22 |
Osteotech, Inc. |
Biocompatible osteogenic band for repair of spinal disorders
|
US20020114795A1
(en)
|
2000-12-22 |
2002-08-22 |
Thorne Kevin J. |
Composition and process for bone growth and repair
|
TWI329129B
(en)
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
US7232802B2
(en)
|
2001-12-21 |
2007-06-19 |
Zimmer Orthobiologics, Inc. |
Compositions and methods for promoting myocardial and peripheral angiogenesis
|
CH695985A5
(en)
|
2002-01-21 |
2006-11-15 |
Straumann Holding Ag |
Surface-modified implants.
|
EP1542711A4
(en)
|
2002-08-13 |
2009-07-01 |
Wyeth Corp |
PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR s PROTEINS
|
JP2006516548A
(en)
|
2002-12-30 |
2006-07-06 |
アンジオテック インターナショナル アクツィエン ゲゼルシャフト |
Drug delivery from rapidly gelled polymer compositions
|
CN1878565B
(en)
|
2003-09-12 |
2011-01-12 |
惠氏公司 |
Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
|
PT1737734E
(en)
|
2004-03-10 |
2010-11-11 |
Scil Technology Gmbh |
Coated implants, their manufacturing and use thereof
|
AU2005247871A1
(en)
|
2004-04-27 |
2005-12-08 |
Research Development Foundation |
Antagonism of TGF-beta superfamily receptor signaling
|
CA2567405A1
(en)
|
2004-05-25 |
2005-12-08 |
Stryker Corporation |
Use of morphogenic proteins for treating cartilage defects
|
US7749268B2
(en)
|
2004-05-26 |
2010-07-06 |
Warsaw Orthopedic, Inc. |
Methods for treating the spine
|
ES2561048T3
(en)
|
2004-07-23 |
2016-02-24 |
Acceleron Pharma Inc. |
ActRII receptor polypeptides
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
WO2006081379A1
(en)
*
|
2005-01-26 |
2006-08-03 |
Wyeth |
Use of sfrps as markers of bmp activity
|
EP1863518A2
(en)
*
|
2005-03-30 |
2007-12-12 |
Wyeth |
Methods for stimulating hair growth by administering bmps
|
US8506646B2
(en)
|
2005-04-29 |
2013-08-13 |
Warsaw Orthopedic, Inc. |
Multi-purpose medical implant devices
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
KR20160137665A
(en)
|
2005-11-23 |
2016-11-30 |
악셀레론 파마 인코포레이티드 |
Activin-actrπa antagonists and uses for promoting bone growth
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
CA2641860C
(en)
|
2006-02-09 |
2015-07-14 |
Biomimetic Therapeutics, Inc. |
Compositions and methods for treating bone
|
EP2035030A2
(en)
|
2006-05-17 |
2009-03-18 |
Stryker Corporation |
Use of a soluble morphogenic protein complex for treating cartilage defects
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
JP5484047B2
(en)
|
2006-06-30 |
2014-05-07 |
バイオミメティック セラピューティクス, エルエルシー |
PDGF-biomatrix composition and method for treating rotator cuff injury
|
US8524265B2
(en)
|
2006-08-17 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Medical implant sheets useful for tissue regeneration
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
US7718616B2
(en)
|
2006-12-21 |
2010-05-18 |
Zimmer Orthobiologics, Inc. |
Bone growth particles and osteoinductive composition thereof
|
AU2008211007B2
(en)
|
2007-02-01 |
2013-09-19 |
Acceleron Pharma Inc. |
Activin-ActRIIa antagonists and uses for treating or preventing breast cancer
|
TW202021980A
(en)
|
2007-02-02 |
2020-06-16 |
美商艾瑟勒朗法瑪公司 |
Variants derived from actriib and uses therefor
|
CA3039330C
(en)
|
2007-02-09 |
2021-11-09 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for promoting bone growth in cancer patients
|
CN107412734A
(en)
|
2007-09-18 |
2017-12-01 |
阿塞勒隆制药公司 |
Activin A CTRIIA antagonists and the purposes for reducing or suppressing FSH secretions
|
JP5922928B2
(en)
|
2008-08-14 |
2016-05-24 |
アクセルロン ファーマ, インコーポレイテッド |
Use of GDF traps to increase red blood cell levels
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
AU2009291828C1
(en)
|
2008-09-09 |
2016-03-17 |
Biomimetic Therapeutics, Llc |
Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
|
EP2387412A4
(en)
|
2009-01-13 |
2013-04-03 |
Acceleron Pharma Inc |
Methods for increasing adiponectin
|
US8609127B2
(en)
|
2009-04-03 |
2013-12-17 |
Warsaw Orthopedic, Inc. |
Medical implant with bioactive material and method of making the medical implant
|
EP2440576A4
(en)
|
2009-06-08 |
2013-11-20 |
Acceleron Pharma Inc |
Methods for increasing thermogenic adipocytes
|
WO2010144696A1
(en)
|
2009-06-11 |
2010-12-16 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
AU2010263182B2
(en)
|
2009-06-12 |
2016-05-12 |
Acceleron Pharma Inc. |
Truncated ActRIIB-Fc fusion proteins
|
US9399086B2
(en)
|
2009-07-24 |
2016-07-26 |
Warsaw Orthopedic, Inc |
Implantable medical devices
|
CA2781152A1
(en)
|
2009-11-17 |
2011-05-26 |
Acceleron Pharma Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
JP6144049B2
(en)
|
2010-02-22 |
2017-06-07 |
バイオミメティック セラピューティクス,リミテッド ライアビリティ カンパニー |
Platelet-derived growth factor compositions and methods for treating tendon disorders
|
WO2011139594A2
(en)
|
2010-04-27 |
2011-11-10 |
Medtronic, Inc. |
Artificial bursa for intra-articular drug delivery
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
SG186180A1
(en)
|
2010-06-09 |
2013-01-30 |
Semprus Biosciences Corp |
Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
|
EP2579906A4
(en)
|
2010-06-09 |
2016-03-23 |
Arrow Int Inc |
Articles having non-fouling surfaces and processes for preparing the same without altering bulk physical properties
|
CA2799786A1
(en)
|
2010-06-09 |
2011-12-15 |
Semprus Biosciences Corp. |
Non-fouling, anti-microbial, anti-thrombogenic graft compositions
|
CA2808655C
(en)
|
2010-08-18 |
2019-11-26 |
Emory University |
Compounds and compositions for ossification and methods related thereto
|
CA2817008A1
(en)
|
2010-11-08 |
2012-05-18 |
Acceleron Pharma Inc. |
Actriia binding agents and uses thereof
|
JP2013542837A
(en)
|
2010-11-15 |
2013-11-28 |
ジンマー オーソバイオロジクス,インコーポレイティド |
Bone void filler
|
EP2678052B1
(en)
|
2011-02-24 |
2018-09-26 |
Emory University |
Jab1 blocking compositions for ossification and methods related thereto
|
CA2827392A1
(en)
|
2011-02-24 |
2012-08-30 |
Emory University |
Noggin blocking compositions for ossification and methods related thereto
|
US8998925B2
(en)
|
2011-06-20 |
2015-04-07 |
Rdc Holdings, Llc |
Fixation system for orthopedic devices
|
WO2012177759A1
(en)
|
2011-06-20 |
2012-12-27 |
Rdc Holdings, Llc |
System and method for repairing joints
|
EP2791223A4
(en)
|
2011-12-14 |
2015-11-18 |
Semprus Biosciences Corp |
Surface modified contact lenses
|
EP2791213A4
(en)
|
2011-12-14 |
2015-10-28 |
Semprus Biosciences Corp |
Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants
|
AU2012351991B2
(en)
|
2011-12-14 |
2015-09-24 |
Semprus Biosciences Corp. |
Multistep UV process to create surface modified contact lenses
|
CA2859047C
(en)
|
2011-12-14 |
2017-03-21 |
Semprus Biosciences Corp. |
Redox processes for contact lens modification
|
AU2012368232B2
(en)
|
2011-12-14 |
2016-01-07 |
Arrow International, Inc. |
Imbibing process for contact lens surface modification
|
US9809636B2
(en)
|
2012-04-06 |
2017-11-07 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels comprising administering BMP9
|
US10034945B2
(en)
|
2012-07-13 |
2018-07-31 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
US9833481B2
(en)
*
|
2012-09-01 |
2017-12-05 |
Ken Muneoka |
Method for articular cartilage and joint formation
|
ES2884095T3
(en)
|
2012-11-02 |
2021-12-10 |
Celgene Corp |
Activin-actrii antagonists and uses for treating bone and other disorders
|
WO2014172692A1
(en)
|
2013-04-19 |
2014-10-23 |
Theracell, Inc. |
Demineralized bone fibers having controlled geometry and shapes and methods thereof
|
BR122023023170A2
(en)
|
2014-06-13 |
2024-02-20 |
Acceleron Pharma Inc. |
USE OF AN ACTRII ANTAGONIST IN THE TREATMENT OR PREVENTION OF SKIN ULCERS ASSOCIATED WITH BETA-THALASSEMIA
|
GB201412290D0
(en)
|
2014-07-10 |
2014-08-27 |
Cambridge Entpr Ltd |
Novel use
|
MA41052A
(en)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
TREATMENT OF CARDIOVASCULAR DISEASE USING ACTRII LIGAND TRAPS
|
JP2016091701A
(en)
|
2014-10-31 |
2016-05-23 |
北川工業株式会社 |
Contact member
|
MD4801C1
(en)
|
2014-12-03 |
2022-10-31 |
Celgene Corporation |
Activin-ActRII antagonists and uses for treating myelodysplastic syndromes
|
WO2016123583A1
(en)
|
2015-01-29 |
2016-08-04 |
Theracell, Inc. |
Demineralized bone fiber composition for use in minimally invasive surgery
|
PE20180041A1
(en)
|
2015-06-05 |
2018-01-09 |
Novartis Ag |
ANTIBODIES TARGETING BONE MORPHOGENETIC PROTEIN (BMP9) AND METHODS FROM THESE
|
CA2986753A1
(en)
|
2015-06-17 |
2016-12-22 |
Warsaw Orthopedic, Inc. |
Implants including an oxysterol and methods of use
|
JP7025021B2
(en)
|
2015-10-26 |
2022-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Reduced and oxidized polysaccharides and methods of their use
|
US10688222B2
(en)
|
2016-11-21 |
2020-06-23 |
Warsaw Orthopedic, Inc. |
Lyophilized moldable implants containing an oxysterol
|
US10639157B2
(en)
|
2017-03-14 |
2020-05-05 |
Theracell, Inc. |
Demineralized bone fiber composition for use in minimally invasive surgery
|
US11464888B2
(en)
|
2017-06-12 |
2022-10-11 |
Warsaw Orthopedic, Inc. |
Moldable formulations containing an oxysterol in an acellular tissue matrix
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|
US11498880B2
(en)
|
2019-07-26 |
2022-11-15 |
Warsaw Orthopedic, Inc. |
Calcium phosphate granules and methods of making them
|